Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study

Lignende værker

• A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention
  af: Kassaian, Seyed-Ebrahim, et al.
  Udgivet: (2015)
• Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial
  af: Hossein Farshidi, et al.
  Udgivet: (2025-03-01)
• Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort
  af: Franey, Ericha G, et al.
  Udgivet: (2020)
• Mean Platelet Volume as a Predictor of One-Year Major Adverse Cardiac Events following Elective Percutaneous Coronary Interventions
  af: Nozari, Younes, et al.
  Udgivet: (2014)
• Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality
  af: Christos Eftychiou, et al.
  Udgivet: (2021-01-01)